CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 

Amgen Inc 's Quick Ratio

AMGN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




AMGN Quick Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Change -3.44 % -13.49 % 0.13 % 4.56 % 49.12 %
Y / Y Cash & cash equivalent Change -11.17 % -11.12 % -38.07 % -24.51 % 4.54 %
Quick Ratio MRQ 0.8 0.57 0.51 0.66 0.87
Overall Ranking # # # # #
Seq. Current Liabilities Change 13.58 % -2.08 % 5.76 % -17.91 % 1.76 %
Seq. Cash & cash equivalent Change 59.79 % 9.76 % -18.58 % -37.8 % 59.87 %



Quick Ratio third quarter 2022 Comment
Amgen Inc 's Cash & cash equivalent grew by 59.79 % in the III. Quarter sequntially, faster than Current Liabilities, this led to improvement in Amgen Inc 's Quick Ratio to 0.8, above Amgen Inc average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry Amgen Inc booked the highest Quick Ratio than Amgen Inc in the third quarter 2022. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are AMGN Segments?
See Quick Ratio AMGN on the trailing twelve month basis
Quick Ratio third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Amgen Inc 's Current Liabilities $ 14,331 Millions Visit AMGN's Balance sheet
Amgen Inc 's Cash & cash equivalent $ 11,478 Millions Visit AMGN's Balance sheet
Source of AMGN's Sales Visit AMGN's Sales by Geography


Cumulative Amgen Inc 's Quick Ratio

AMGN's Quick Ratio for the trailling 12 Months

AMGN Quick Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities TTM Growth -3.44 % -13.49 % 0.13 % 4.56 % 49.12 %
Y / Y Cash & cash equivalent TTM Growth -11.17 % -11.12 % -38.07 % -24.51 % 4.54 %
Quick Ratio TTM 0.64 0.66 0.65 0.73 0.78
Total Ranking TTM # 624 # 2685 # 2814 # 1597 # 892
Seq. Current Liabilities TTM Growth 13.58 % -2.08 % 5.76 % -17.91 % 1.76 %
Seq. Cash & cash equivalent TTM Growth 59.79 % 9.76 % -18.58 % -37.8 % 59.87 %


TTM Quick Ratio Comment
On the trailing twelve months basis In spite of the year on year decrease in AMGN's average Current Liabilities to $14,331.00 millions, Quick Ratio to 0.64 below company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 57 other companies have achieved higher Quick Ratio than Amgen Inc . While overall ranking remained unchanged compare to previous quarter at no. 624.

Explain Quick Ratio?
What are AMGN Segments?
See Quick Ratio AMGN on the trailing twelve month basis

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 58
Healthcare Sector # 226
Within the Market # 624


TTM Quick Ratio Statistics
High Average Low
4.52 2.33 0.64
(Dec 31 2017)   (Sep 30 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Logicbio Therapeutics Inc   2.04 $ 30.780  Millions$ 15.098  Millions
Establishment Labs Holdings Inc   2.02 $ 65.349  Millions$ 32.376  Millions
Ayala Pharmaceuticals Inc   1.96 $ 11.195  Millions$ 5.705  Millions
Telesis Bio Inc   1.93 $ 24.741  Millions$ 12.808  Millions
Edwards Lifesciences Corporation  1.89 $ 1,738.700  Millions$ 917.900  Millions
Biocardia Inc  1.81 $ 6.667  Millions$ 3.684  Millions
Myomo Inc   1.80 $ 7.420  Millions$ 4.114  Millions
Pluri Inc   1.74 $ 8.744  Millions$ 5.018  Millions
Cue Health Inc   1.74 $ 304.654  Millions$ 175.462  Millions
Titan Pharmaceuticals inc   1.69 $ 4.450  Millions$ 2.630  Millions
Bluebird Bio Inc   1.68 $ 139.633  Millions$ 82.936  Millions
Coherus Biosciences inc   1.67 $ 286.805  Millions$ 171.319  Millions
Neurocrine Biosciences Inc   1.65 $ 799.400  Millions$ 485.100  Millions
Cidara Therapeutics Inc   1.61 $ 53.078  Millions$ 33.049  Millions
Meiragtx Holdings Plc  1.59 $ 114.706  Millions$ 72.363  Millions
Immunitybio inc   1.57 $ 111.057  Millions$ 70.840  Millions
Xtant Medical Holdings Inc   1.53 $ 17.363  Millions$ 11.359  Millions
Bio techne Corp  1.48 $ 203.075  Millions$ 137.629  Millions
Repligen Corp  1.44 $ 573.363  Millions$ 397.540  Millions
Idera Pharmaceuticals Inc   1.39 $ 26.795  Millions$ 19.231  Millions
Myriad Genetics Inc   1.35 $ 193.200  Millions$ 142.800  Millions
Ladrx Corporation  1.33 $ 3.016  Millions$ 2.259  Millions
Mink Therapeutics Inc   1.31 $ 24.159  Millions$ 18.448  Millions
Aerie Pharmaceuticals Inc   1.29 $ 172.464  Millions$ 133.333  Millions
Applied Genetic Technologies Corporation  1.29 $ 34.241  Millions$ 26.604  Millions
Precipio inc   1.27 $ 5.144  Millions$ 4.035  Millions
Agenus Inc  1.26 $ 218.230  Millions$ 173.073  Millions
Moderna Inc   1.23 $ 8,348.000  Millions$ 6,807.000  Millions
Nanovibronix Inc  1.17 $ 1.972  Millions$ 1.687  Millions
Axcella Health Inc   1.15 $ 25.425  Millions$ 22.110  Millions

Date modified: 2022-11-06T23:41:51+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NUS's Profile

Stock Price

NUS's Financials

Business Description

Fundamentals

Charts & Quotes

NUS's News

Suppliers

NUS's Competitors

Customers & Markets

Economic Indicators

NUS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071